Cargando…

Feasibility of Quantitative Magnetic Resonance Fingerprinting in Ovarian Tumors for T(1) and T(2) Mapping in a PET/MR Setting

Multiparametric magnetic resonance imaging (MRI) can be used to characterize many cancer subtypes including ovarian cancer. Quantitative mapping of MRI relaxation values, such as T(1) and T(2) mapping, is promising for improving tumor assessment beyond conventional qualitative T(1)- and T(2)-weighte...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaggie, Joshua D., Deen, Surrin, Kessler, Dimitri A., McLean, Mary A., Buonincontri, Guido, Schulte, Rolf F., Addley, Helen, Sala, Evis, Brenton, James, Graves, Martin J., Gallagher, Ferdia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025887/
https://www.ncbi.nlm.nih.gov/pubmed/32066996
http://dx.doi.org/10.1109/TRPMS.2019.2905366
Descripción
Sumario:Multiparametric magnetic resonance imaging (MRI) can be used to characterize many cancer subtypes including ovarian cancer. Quantitative mapping of MRI relaxation values, such as T(1) and T(2) mapping, is promising for improving tumor assessment beyond conventional qualitative T(1)- and T(2)-weighted images. However, quantitative MRI relaxation mapping methods often involve long scan times due to sequentially measuring many parameters. Magnetic resonance fingerprinting (MRF) is a new method that enables fast quantitative MRI by exploiting the transient signals caused by the variation of pseudorandom sequence parameters. These transient signals are then matched to a simulated dictionary of T(1) and T(2) values to create quantitative maps. The ability of MRF to simultaneously measure multiple parameters, could represent a new approach to characterizing cancer and assessing treatment response. This feasibility study investigates MRF for simultaneous T(1), T(2), and relative proton density (rPD) mapping using ovarian cancer as a model system.